Pfizer, Inc. v. Rite Aid Corp.
- Case Date: 12/21/2017
- Project Name: Health Care Project
On December 21, 2017, WLF called on the U.S. Supreme Court to review and overturn a decision by the U.S. Court of Appeals for the Third Circuit that requires exacting antitrust scrutiny for virtually any agreement between a brand-name drug company and a generic drug company to settle patent-infringement litigation. The brief argues that the appeals court decision expands antitrust law dramatically and makes it almost impossible for litigants to settle drug-patent disputes.
More Information and Downloads:
12/21/2017: Download the Brief